Anthos Therapeutics Inc

Anthos Therapeutics, Inc. develops therapies in the biopharmaceutical sector. The Company advances treatments and conducts clinical trials for prevention and management of arterial and venous thromboembolism in high-risk cardiovascular patients. Anthos Therapeutics Inc serves patients with atrial fibrillation and cancer-associated thrombosis in Europe, Asia, and the United States.